论文部分内容阅读
业已证实,铁是慢性丙型肝炎(CHC)肝组织损害的危险因子,放血疗法可以降低血清铁蛋白水平,从而降低血清ALT活性。作者的研究观察了持续放血疗法对改善CHC患者肝功能和减缓其肝纤维化进展的作用。 研究对象为29例抗-HCV、HCV RNA阳性,ALT异常1年以上的CHC患者(平均年龄51岁)。治疗
It has been demonstrated that iron is a risk factor for liver damage in chronic hepatitis C (CHC) and that bleeding therapy reduces serum ferritin levels and thus serum ALT activity. The authors’ study looked at the effects of continuous bleeding therapy on improving liver function and slowing the progression of liver fibrosis in CHC patients. The study population consisted of 29 CHC patients (mean age 51 years) with anti-HCV, HCV RNA positive and ALT abnormalities of more than 1 year. treatment